WHC is still in active development. Read this to understand our approach.
depiction of ALBKMJDFBZVHAK-UHFFFAOYSA-N.svg
isomerdesign

ZK-93423

Verificar en isomerdesign

drugmap

ZK-93423

Verificar en drugmap

wiki

ZK-93423

Verificar en wiki

Data

InChI: InChI=1S/C23H22N2O4/c1-3-28-23(26)22-18(14-27-2)21-17-11-16(29-13-15-7-5-4-6-8-15)9-10-19(17)25-20(21)12-24-22/h4-12,25H,3,13-14H2,1-2H3

Sinónimos: ZINC5857871, CHEBI:92593, PDSP1_001754, SCHEMBL7117282, GTPL4346,ZK-93423, ethyl 6-(benzyloxy)-4-(methoxymethyl)-9h-, ZK 93 423, CHEMBL1518572, 9H-Pyrido(3,4-b)indole-3-carboxylic acid, 4-(methoxymethyl)-6-(phenylmethoxy)-, ethyl ester, CHEMBL10947, 83910-44-5, BDBM50007553, PDSP2_001754,ZK 93423, CAS_121926, BDBM85039, PDSP1_001771, NSC_121926, ALBKMJDFBZVHAK-UHFFFAOYSA-N, ZK93423, AC1L3TNV, 6-Benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylic acid ethyl ester, PDSP2_001737, AC1Q64YI

Estimated data

Solubilidad: -5.896 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 45.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.